Christos Andriopoulos – Managing Director, Merck Belgium & Luxembourg
Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations…
Address: Brusselsesteenweg 288 B-3090 Overijse,Belgium
Tel: + 32 2 686 07 11
Web: http://www.merck.be/en/index.html;jsessionid=8831CEDDDC85C9799B4532C35705E349
Merck has been active in Belgium since 1951, when the first representation was opened.
Merck in Belgium is active in the marketing and sales of products from all of its divisions including:
Merck SeronoMerck Consumer HealthMerck Performance MaterialsMerck Millipore
Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations…
In your 8 years of experience within the group, how would you classify the competitive advantages derived for the…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…